According to the global medical membrane market report by IMARC Group, the market reached a value of US$ 3.6 Billion in 2022, and it is projected to reach a value of US$ 5.9 Billion by 2028, exhibiting a CAGR of 8.35% during 2023-2028.
Medical membrane represents synthetic membranes that are utilized in several medical applications for filtration and separation. Based on materials, they can be categorized into acrylics polypropylene (PP), polysulfone (PSU), polyvinylidene fluoride (PVDF), polyether sulfone (PESU), etc. These medical membrane variants are designed to filter out bacteria, fungi, fine particles, and various toxins from the blood through aqueous solutions and superior flow rates. They prove to be instrumental in the concentration, separation, and purification of multiple medical processes.
Medical membrane materials even act as selective barriers for preventing immune system components from inadvertently interacting with implants while permitting nutrients and metabolites to enter cells freely. They play an important role in the production of an extensive range of diagnostic devices. Consequently, medical membrane products find widespread utilization in pharmaceutical filtration, bio-artificial processes, IV infusion and sterile filtration, drug delivery, hemodialysis, etc.
Request For Sample Report:https://www.imarcgroup.com/medical-membrane-market/requestsample
The growing prevalence of numerous chronic diseases, including renal failure, diabetes, atherosclerosis, etc., across the globe, is among the key factors driving the medical membrane market. In line with this, the rising use of membranes in dialysis for filtration and blood purification and in the recovery of concentrated proteins and enzymes is acting as another significant growth-inducing factor.
Moreover, the escalating requirement of medical membrane devices, which include microfiltration and intravenous (IV) infusion filters for curing multiple ailments, is also positively influencing the market growth. Apart from this, the inflating demand for artificial organ implants, owing to organ failure, is further stimulating the global market. Additionally, the expanding product usage for wastewater treatment, on account of its higher selectivity towards critical components, is expected to bolster the medical membrane market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.
|Medical Membrane Market Report Scope|
|Market size value in 2022||US$ 3.6 Billion|
|Market forecast in 2028||US$ 5.9 Billion|
|Growth Rate||CAGR of 8.35% from 2023 to 2028|
|Base year for estimation||2022|
|Report coverage||Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends|
|Segments covered||Technology, Material And Application|
|Regional scope||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Key companies profiled||3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization purview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Breakup by Technology:
- Gas Filtration
Breakup by Material:
- Polypropylene (PP)
- Polyvinylidene Fluoride (PVDF)
- Polysulfone (PSU) and Polyether Sulfone (PESU)
- Polytetrafluoroethylene (PTFE)
Breakup by Application:
- Pharmaceutical Filtration
- IV Infusion and Sterile Filtration
- Bio-Artificial Processes
- Drug Delivery
- Asia Pacific
- North America
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800